How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
Security | Price | Target price |
---|---|---|
NVIDIA Corp. | €147.36 | €171.16 |
MongoDB Inc. | €277.00 | €307.19 |
Broadcom Ltd. | €303.60 | €312.91 |
Security | Price | Target price |
---|---|---|
Kohl's Corp. | €13.94 | €7.33 |
Campbell Soup Co. | €28.21 | €29.53 |
Beyond Meat Inc | €2.32 | €1.77 |
New Top predictions since last week
Prediction | User | Perf. (%) |
---|---|---|
B NorCom Information Technology GmbH & Co. KGAA | Warner | 50.72% |
B Kala Pharmaceuticals Inc. | Oppenheimer Holdings Inc. | 16.49% |
B APA Corporation | Raymond James | 11.70% |
Prediction | User | Perf. (%) |
---|---|---|
S aTyr Pharma Inc | bundfuture | -83.57% |
S aTyr Pharma Inc | BiotechBee | -83.57% |
S Cocrystal Pharma Inc. | thomasw | -58.50% |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Financial analysis of Continental Airlines B
Financial Report Analysis for CALERES INC (CAL)
1. Executive Summary
- Current Financial Position: CALERES INC reported revenue of $683.3 million and profit of $29.96 million for Q3 2025.
- Key Findings:
- Revenue decreased compared to the previous year's same quarter ($683.3 million vs $658.5 million in Q3 2024, as per income statement data for the respective periods).
- Profit significantly decreased year-over-year ($29.96 million in Q3 2024 vs $6.71 million in Q3 2025).
- Cash and cash equivalents increased to $191.5 million as of Aug 02, 2025.
- Overall Trend: The financial trend appears mixed, with revenue growth but significant profit decline.
2. Profitability Analysis
- Revenue Trend: Revenue increased from $658.5 million in Q3 2024 to $683.3 million in Q3 2025.
- Profit Trend: Profit decreased substantially from $29.96 million in Q3 2024 to $6.71 million in Q3 2025.
- Profit Margins:
- Gross profit margin decreased from 45.5% ($310.9 million/$683.3 million) in Q3 2024 to 43.4% ($285.8 million/$658.5 million) in Q3 2025.
- Operating income margin decreased from 6.2% ($42.5 million/$683.3 million) in Q3 2024 to 1.4% ($9.3 million/$658.5 million) in Q3 2025.
- Operating Efficiency: Selling, general, and administrative expenses remained relatively stable at around $268-269 million, indicating consistent operational costs.
3. Balance Sheet Strength
- Assets: Total assets increased to $2.152 billion as of Aug 02, 2025, from $2.02 billion as of Aug 03, 2024.
- Liabilities: Total current liabilities increased to $1.015 billion from $860.4 million year-over-year.
- Equity: Stockholders' equity (including non-controlling interest) increased to $621.9 million from $613.5 million.
- Liquidity: Cash and cash equivalents increased to $191.5 million from $51.8 million year-over-year, improving liquidity.
- Solvency: The company's debt (lines of credit) increased significantly to $387.5 million from $146.5 million, potentially affecting solvency.
4. Cash Flow Assessment
- Operating Cash Flow: Net cash provided by operating activities was $41.6 million in Q3 2025, down from $115.7 million in Q3 2024.
- Investing Cash Flow: Net cash used in investing activities was $34.1 million in Q3 2025, slightly higher than $21.8 million in Q3 2024.
- Financing Cash Flow: Net cash provided by financing activities was $154.2 million in Q3 2025, significantly improved from -$63.4 million in Q3 2024, mainly due to increased borrowing.
- Cash Generation: The company generated $161.9 million in net cash during Q3 2025, significantly higher than $30.4 million in Q3 2024.
5. Growth and Investment
- Capital Expenditures: Payments to acquire property, plant, and equipment increased to $32.9 million from $20.9 million year-over-year.
- R&D Investments: Not directly available, but software payments increased to $1.2 million from $0.9 million.
- Growth Trajectory: Revenue growth is positive, but profit decline indicates potential challenges.
6. Risk Factors
- Financial Risks: Increased debt levels and declining profitability pose financial risks.
- Concerning Trends: Significant decrease in net income and increased reliance on borrowing.
- Financial Resilience: The company's cash position has improved, but high debt levels may strain future cash flows.
7. Valuation Context
- Earnings Per Share (EPS): Diluted EPS decreased from $0.85 in Q3 2024 to $0.20 in Q3 2025.
- Valuation Metrics: Not directly calculable without stock price data, which is null in the provided information.
8. Key Considerations
- Key Factors for Investors:
- The significant decline in profitability despite revenue growth.
- Increased debt levels and potential impact on future cash flows.
- Improved cash and cash equivalents position.
- Strengths: Increased revenue and improved cash position.
- Challenges: Declining profitability and increasing debt.
- Trends/Anomalies: The substantial year-over-year decrease in net income warrants further investigation into operational efficiencies and cost management.
Portfolios of our members
Krypto 2
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Turbo Energy S.a.
WKN: A3D9PT / Name: Turbo Energy S.a. / Stock / ? /
Pros
Cons
Birks Group Inc
WKN: A1W6EZ / Name: Birks Group Inc / Stock / Textiles & Apparel / Micro Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
Security | Price | Change(%) (%) |
---|---|---|
Apartment Investment & Management Co | €7.00 | 10.240% |
APA Corporation | €20.57 | 5.610% |
Discovery Communications C | €22.42 | 5.110% |
Lam Research Corp. | €7,371.0 | 3.990% |
Westrock Co | €47.53 | 3.930% |
Security | Price | Change(%) (%) |
---|---|---|
Warner Bros. Discovery Inc. | €15.30 | -7.640% |
Lumen Technologies Inc. | €4.64 | -6.570% |
Lincoln National | €33.00 | -5.850% |
Gap Inc. | €19.17 | -5.750% |
Emerson Electric Company | €109.00 | -5.500% |
Courses

sharewise Introduction

Key figures for stocks
Predictions
Top News

2 Falling Knives That Might Be Worth Catching
With the major indices continuing to set fresh records, it can be tough for investors to feel comfortable buying into names already trading at highs. However, at the other end of the spectrum, it

Uranium Energy Stock Has Momentum—and More Upside Ahead
Today's energy sector is on the cusp of one of its most transformative shifts in history. While many investors might not see it yet, the reality is that the transition from traditional to

If a Recession Is Coming, You'll Want to Own These 2 Stocks
While no business is recession-proof, specific sectors offer investors recession-resistant stocks whose products and services are inelastic in demand—even during market or economic downturns. With

3 Under-the-Radar Stocks Set to Benefit From Oracle’s Boom
On Sept. 9, one of the world’s biggest tech stocks, Oracle (NYSE: ORCL), provided key information that blew investors away. Shares closed up by 36% on Sept. 10 in reaction to the company's

Lululemon’s Sell-Off Looks Overdone: A Contrarian Case
Lululemon Athletica Inc. (NASDAQ: LULU) has to be one of the most painful charts for retail investors to look at this year. After gaining nearly 90% through the end of January, shares are now

5 Countries Where Casino Stock Investments Make Strong Sense

How to Choose the Best Crypto Exchange for Beginners

American Express Expands Premium Travel With New Digital Features
American Express Company AXP is once again setting the standards for premium travel by launching a wide range of new digital features aimed at making the trip easier and more enjoyable for its card

Krystal Biotech Stock Up on FDA Nod to Vyjuvek Label Update
Krystal Biotech KRYS announced that the FDA has approved a label update of its marketed product, Vyjuvek (beremagene geperpavec-svdt), to include dystrophic epidermolysis bullosa ("DEB") patients

CoreWeave Rises 25% in a Month: Is There More Room for Growth?
CoreWeave, Inc. CRWV stock has gained 24.5% in the past month, significantly outperforming the Zacks Internet-Software Market’s gain of 1.9% while the Zacks Computer & Technology sector and the S&P

Uranium ETF (URNJ) Hits New 52-Week High
For investors seeking momentum, Sprott Junior Uranium Miners ETF URNJ is probably on the radar. The fund just hit a 52-week high and has moved up 136.55% from its 52-week low price of $11.52 per
News

PayPal Links Boosts P2P Payments With Crypto & Global Reach
PayPal Holdings PYPL recently unveiled a new feature called PayPal links, which allows users to send and receive money through a personalized, one-time link that can be shared in any conversation

"The most important quality for an investor is temperament, not intellect." --Warren Buffett
THE GRAND ILLUSION
THE GRAND ILLUSION (September 14, 2025): Once every few decades, far too many investors become convinced that if they throw a ball into the air with enough

Photronics Stock Analysis: Uncovering the Security Potential for Investors

4 Stocks Trading Near 52-Week High With More Upside Potential
Investors generally consider a stock's 52-week high a good criterion for an entry or exit point. Stocks touching new 52-week highs are often predisposed to profit-taking, resulting in pullbacks and

Will Rate Cuts Fuel Bitcoin ETF Momentum?
After a volatile August, Bitcoin has been regaining momentum in September, gaining about 5.6% month to date. Growing institutional adoption, a weakening greenback and interest rate cuts by the Fed

Elevated Costs Challenge Coca-Cola: How Will the Brand Adapt?
The Coca-Cola Company KO continues to deliver steady top-line growth, but rising costs remain a pressing challenge that weighs on its near-term profitability. In second-quarter 2025, the company

HCA Healthcare Trades at a Premium: Buy, Hold, or Avoid the Stock?
U.S. hospital operator HCA Healthcare, Inc. HCA is currently trading at a noticeable premium compared with its historical and industry benchmarks. The stock’s forward 12-month price-to-earnings

Apple vs. HP: Which Stock Has an Edge as AI PC Sales Accelerate?
Apple AAPL and HP HPQ are well-known personal computer (PC) makers in a market that is expected to see year-over-year shipment growth of more than 4.1% in 2025, per IDC. Meanwhile, U.S. shipment
Contest
Still running
sharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.

Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobieren
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.